March 24, 2023 — Vaxxinity, Inc., a Cape Canaveral, FL-based company pioneering the development of a new class of immunotherapeutic vaccines, has announced that the first subjects have been dosed in a randomized, double-blind, placebo-controlled Phase 1 clinical trial of VXX-401.

AiMed Summit 2023

The 2023 AiMed Global Summit will focus on artificial intelligence (AI) in healthcare, and will offer valuable insights into the latest use cases, perspectives and novel approaches in healthcare AI. The event is scheduled to take place June 4-7 at the San Diego Convention Center in San Diego, Calif.

March 23, 2023 — Newly-published research has debunked the idea that there is an “obesity paradox,” whereby patients with heart failure who are overweight or obese are thought to be less likely to end up in hospital or die than people of normal weight.

March 22, 2023 — Viz.ai, a leader in AI-powered disease detection and intelligent care coordination, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its algorithm intended to detect suspected abdominal aortic aneurysm (AAA). Viz AAA is the first FDA-cleared AI-powered solution for the detection and triage of suspected AAA. 

March 22, 2023 — Brainomix, the AI-powered medtech solutions company, today announced that its Brainomix 360 e-ASPECTS tool for stroke has received FDA clearance, enabling the Oxford-based company to deploy its cutting-edge stroke AI imaging platform to US stroke centers.  

March 22, 2023 — Windtree Therapeutics, Inc., a biotechnology company focused on advancing multiple late-stage interventions for cardiovascular disorders, announced that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No.

March 22, 2023 — Ancora Heart, Inc., a privately-held Santa Clara, CA-based company developing a completely transcatheter device-based therapy to address heart failure (HF), has announced that patients treated with the investigational AccuCinch Ventricular Restoration System demonstrated improvement in HF patient outcomes and beneficial changes in the structure of the heart.

March 21, 2023 — As part of its extensive coverage, the editorial team at dicardiology.com/DAIC has shared summary highlights from the 72nd Convocation of the American College of Cardiology’s Annual Scientific Session, which took place on the final day of the ACC Together with the World Congress of Cardiology (ACC.23/WCC).

March 21, 2023 —  Procyrion, Inc., a medical device company dedicated to improving outcomes for patients with cardiac and renal impairment, announced today that use of its Aortix percutaneous mechanical circulatory support (pMCS) device led to rapid decongestion in a pilot study of

ACC's 73rd Annual Scientific Session & Expo

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now